Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel selenoproteins identified from genomic sequence data

Alain Lescure1, Daniel Gautheret, Alain Krol

  • 1Unité Propre de Recherche 9002 du CNRS, Institut de Biologie Moléculaire et Cellulaire, 67084 Strasbourg, France.

Methods in Enzymology
|March 20, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of ctDNA Tumor Fraction in Selecting Immunotherapy Based Regimens in Advanced Non-small Cell Lung Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Regulatory landscape of widespread stop codon readthrough in <i>Drosophila</i>.

bioRxiv : the preprint server for biology·2026
Same author

Metappuccino: large language model-driven reconstruction of sequence read archive metadata for cancer research.

Bioinformatics (Oxford, England)·2026
Same author

Tumor Purity as a Prognostic and Predictive Biomarker of Postoperative Radiation Therapy Outcomes in Stage IIIA-N2 Non-Small Cell Lung Cancer: A Transcriptomic Analysis From the Lung ART Trial.

International journal of radiation oncology, biology, physics·2026
Same author

A specialized bacterial group II intron is a highly efficient retrotransposon.

Mobile DNA·2025
Same author

Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment.

NAR cancer·2025